HEADER TRANSFERASE 03-AUG-15 5D12 TITLE KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 251-533; COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC,PP60C-SRC,P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE INHIBITOR, DRUG RESISTANCE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.BECKER,A.RICHTERS,J.ENGEL,D.RAUH REVDAT 4 08-MAY-24 5D12 1 REMARK REVDAT 3 20-FEB-19 5D12 1 REMARK LINK REVDAT 2 23-SEP-15 5D12 1 JRNL REVDAT 1 09-SEP-15 5D12 0 JRNL AUTH J.ENGEL,A.RICHTERS,M.GETLIK,S.TOMASSI,M.KEUL,M.TERMATHE, JRNL AUTH 2 J.LATEGAHN,C.BECKER,S.MAYER-WRANGOWSKI,C.GRUTTER, JRNL AUTH 3 N.UHLENBROCK,J.KRULL,N.SCHAUMANN,S.EPPMANN,P.KIBIES, JRNL AUTH 4 F.HOFFGAARD,J.HEIL,S.MENNINGER,S.ORTIZ-CUARAN,J.M.HEUCKMANN, JRNL AUTH 5 V.TINNEFELD,R.P.ZAHEDI,M.L.SOS,C.SCHULTZ-FADEMRECHT, JRNL AUTH 6 R.K.THOMAS,S.M.KAST,D.RAUH JRNL TITL TARGETING DRUG RESISTANCE IN EGFR WITH COVALENT INHIBITORS: JRNL TITL 2 A STRUCTURE-BASED DESIGN APPROACH. JRNL REF J.MED.CHEM. V. 58 6844 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26275028 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01082 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 13820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.294 REMARK 3 R VALUE (WORKING SET) : 0.290 REMARK 3 FREE R VALUE : 0.376 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 728 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1051 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 56 REMARK 3 BIN FREE R VALUE : 0.4700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4086 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -3.27000 REMARK 3 B33 (A**2) : 3.18000 REMARK 3 B12 (A**2) : -0.63000 REMARK 3 B13 (A**2) : 1.05000 REMARK 3 B23 (A**2) : -0.40000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.642 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.589 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 30.366 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.827 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.725 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4264 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4018 ; 0.007 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5780 ; 1.980 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9236 ; 1.066 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 513 ; 5.515 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 191 ;36.448 ;23.717 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 724 ;26.511 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;23.201 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 617 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4763 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 991 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2052 ; 1.605 ; 3.389 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2051 ; 1.602 ; 3.389 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2556 ; 2.796 ; 5.074 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2557 ; 2.796 ; 5.074 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2212 ; 1.197 ; 3.373 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2213 ; 1.196 ; 3.372 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3222 ; 2.121 ; 5.037 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5402 ; 4.654 ;27.185 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5403 ; 4.653 ;27.182 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5D12 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000212501. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : PH 6.0 - 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0039 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14548 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 3.090 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.085-0.125 MM MES, 9-11.5 % PEG20000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 248 REMARK 465 HIS A 249 REMARK 465 MET A 250 REMARK 465 GLN A 251 REMARK 465 THR A 252 REMARK 465 GLN A 253 REMARK 465 GLY A 254 REMARK 465 LEU A 255 REMARK 465 ALA A 256 REMARK 465 LYS A 298 REMARK 465 PRO A 299 REMARK 465 GLY A 300 REMARK 465 THR A 301 REMARK 465 MET A 302 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 GLY B 248 REMARK 465 HIS B 249 REMARK 465 MET B 250 REMARK 465 GLN B 251 REMARK 465 THR B 252 REMARK 465 GLN B 253 REMARK 465 GLY B 254 REMARK 465 LEU B 255 REMARK 465 ALA B 256 REMARK 465 LYS B 257 REMARK 465 LYS B 298 REMARK 465 PRO B 299 REMARK 465 GLY B 300 REMARK 465 THR B 301 REMARK 465 MET B 302 REMARK 465 SER B 303 REMARK 465 PRO B 304 REMARK 465 ALA B 408 REMARK 465 ARG B 409 REMARK 465 LEU B 410 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 277 SG REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 LEU A 308 CG CD1 CD2 REMARK 470 ILE A 411 CG1 CG2 CD1 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 CYS B 277 SG REMARK 470 GLU B 280 CG CD OE1 OE2 REMARK 470 LEU B 308 CG CD1 CD2 REMARK 470 GLN B 312 CG CD OE1 NE2 REMARK 470 LYS B 315 CG CD CE NZ REMARK 470 GLU B 320 CG CD OE1 OE2 REMARK 470 GLU B 331 CG CD OE1 OE2 REMARK 470 MET B 354 CG SD CE REMARK 470 PHE B 405 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 424 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 469 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS B 345 OD1 ASP B 348 0.77 REMARK 500 O ALA B 327 CG2 VAL B 337 0.94 REMARK 500 O CYS B 345 OD2 ASP B 348 1.11 REMARK 500 O TRP B 428 OG SER B 447 1.23 REMARK 500 OE2 GLU B 261 OG SER B 330 1.30 REMARK 500 C CYS B 345 OD2 ASP B 348 1.34 REMARK 500 NH2 ARG B 264 O PRO B 333 1.41 REMARK 500 O THR B 453 OG1 THR B 457 1.44 REMARK 500 C ALA B 327 CG2 VAL B 337 1.45 REMARK 500 OG SER A 490 OE1 GLU A 524 1.45 REMARK 500 O TRP A 286 CG2 THR A 290 1.61 REMARK 500 O VAL A 471 CG2 VAL A 475 1.66 REMARK 500 O HIS A 384 OD1 ASP A 444 1.70 REMARK 500 O VAL B 329 CG2 ILE B 334 1.71 REMARK 500 SG CYS B 345 CG ASP B 348 1.76 REMARK 500 NE1 TRP B 428 OE1 GLU B 454 1.77 REMARK 500 O GLU B 331 O PRO B 333 1.80 REMARK 500 O PRO A 425 OG1 THR A 429 1.81 REMARK 500 O THR A 453 OG1 THR A 457 1.85 REMARK 500 CZ2 TRP B 428 OE1 GLU B 454 1.85 REMARK 500 O ILE B 450 OG1 THR B 453 1.85 REMARK 500 OE2 GLU A 378 OG1 THR A 508 1.86 REMARK 500 CE2 TRP B 428 OE1 GLU B 454 1.87 REMARK 500 CD1 ILE A 426 CD1 LEU A 472 1.98 REMARK 500 NZ LYS A 272 OE1 GLN A 275 2.00 REMARK 500 N TRP A 286 O THR A 290 2.03 REMARK 500 CA CYS B 345 OD2 ASP B 348 2.04 REMARK 500 O PRO B 263 OG SER B 266 2.04 REMARK 500 OE2 GLU A 261 OE2 GLU A 331 2.06 REMARK 500 OE2 GLU B 261 CB SER B 330 2.12 REMARK 500 NH2 ARG B 264 O GLU B 331 2.12 REMARK 500 OE1 GLU A 378 OG1 THR A 508 2.13 REMARK 500 O HIS B 384 OD1 ASP B 444 2.15 REMARK 500 O THR B 440 OG SER B 443 2.15 REMARK 500 CA ALA B 327 CG2 VAL B 337 2.16 REMARK 500 O CYS B 345 CG ASP B 348 2.17 REMARK 500 O TRP A 428 OG SER A 447 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN B 397 CG ARG B 438 1655 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 526 CA GLN A 526 C 0.167 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 525 C - N - CA ANGL. DEV. = 15.1 DEGREES REMARK 500 PRO A 525 C - N - CD ANGL. DEV. = -13.1 DEGREES REMARK 500 GLN A 526 C - N - CA ANGL. DEV. = 15.2 DEGREES REMARK 500 GLN A 526 C - N - CA ANGL. DEV. = 21.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 266 -3.06 84.59 REMARK 500 PHE A 278 76.97 35.63 REMARK 500 TYR A 326 -45.23 -130.48 REMARK 500 ASN A 397 12.54 86.43 REMARK 500 LEU A 407 -6.28 82.53 REMARK 500 GLU A 486 -1.85 74.47 REMARK 500 PRO A 507 -175.50 -60.68 REMARK 500 GLN B 275 -69.78 -120.33 REMARK 500 ASN B 287 -51.57 72.03 REMARK 500 ALA B 306 68.26 -152.83 REMARK 500 PHE B 307 63.87 -151.30 REMARK 500 LEU B 308 156.16 177.76 REMARK 500 LYS B 316 0.63 -68.80 REMARK 500 ASP B 386 60.09 -158.16 REMARK 500 GLU B 489 -31.29 -32.95 REMARK 500 GLU B 489 -9.27 -56.18 REMARK 500 LYS B 501 -1.13 -58.60 REMARK 500 LYS B 501 -1.06 -59.51 REMARK 500 THR B 521 -63.96 -105.25 REMARK 500 ASN B 532 -58.60 -128.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G97 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G97 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ARG B 264 and PRO B REMARK 800 333 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ALA B 327 and VAL B REMARK 800 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CYS B 345 and ASP B REMARK 800 348 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide CYS B 345 and ASP B REMARK 800 348 DBREF 5D12 A 251 533 UNP P00523 SRC_CHICK 251 533 DBREF 5D12 B 251 533 UNP P00523 SRC_CHICK 251 533 SEQADV 5D12 GLY A 248 UNP P00523 EXPRESSION TAG SEQADV 5D12 HIS A 249 UNP P00523 EXPRESSION TAG SEQADV 5D12 MET A 250 UNP P00523 EXPRESSION TAG SEQADV 5D12 MET A 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 5D12 CYS A 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQADV 5D12 GLY B 248 UNP P00523 EXPRESSION TAG SEQADV 5D12 HIS B 249 UNP P00523 EXPRESSION TAG SEQADV 5D12 MET B 250 UNP P00523 EXPRESSION TAG SEQADV 5D12 MET B 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 5D12 CYS B 345 UNP P00523 SER 345 ENGINEERED MUTATION SEQRES 1 A 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 A 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 A 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 A 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 A 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 A 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 A 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 A 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 A 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 A 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 A 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 A 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 A 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 A 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 A 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 A 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 A 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 A 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 A 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU SEQRES 1 B 286 GLY HIS MET GLN THR GLN GLY LEU ALA LYS ASP ALA TRP SEQRES 2 B 286 GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL LYS LEU SEQRES 3 B 286 GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY THR TRP SEQRES 4 B 286 ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU LYS PRO SEQRES 5 B 286 GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU ALA GLN SEQRES 6 B 286 VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL GLN LEU SEQRES 7 B 286 TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE VAL MET SEQRES 8 B 286 GLU TYR MET SER LYS GLY CYS LEU LEU ASP PHE LEU LYS SEQRES 9 B 286 GLY GLU MET GLY LYS TYR LEU ARG LEU PRO GLN LEU VAL SEQRES 10 B 286 ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA TYR VAL SEQRES 11 B 286 GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG ALA ALA SEQRES 12 B 286 ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS VAL ALA SEQRES 13 B 286 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 B 286 THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 B 286 ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR ILE LYS SEQRES 16 B 286 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU LEU SEQRES 17 B 286 THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET VAL ASN SEQRES 18 B 286 ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR ARG MET SEQRES 19 B 286 PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS ASP LEU SEQRES 20 B 286 MET CYS GLN CYS TRP ARG LYS ASP PRO GLU GLU ARG PRO SEQRES 21 B 286 THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP TYR PHE SEQRES 22 B 286 THR SER THR GLU PRO GLN TYR GLN PRO GLY GLU ASN LEU HET G97 A 601 27 HET G97 B 601 27 HETNAM G97 N-[2-PHENYL-4-(1H-PYRAZOL-3-YLAMINO)QUINAZOLIN-7- HETNAM 2 G97 YL]PROP-2-ENAMIDE HETSYN G97 N-(4-(1H-PYRAZOL-3-YLAMINO)-2-PHENYLQUINAZOLIN-7-YL) HETSYN 2 G97 ACRYLAMIDE FORMUL 3 G97 2(C20 H16 N6 O) HELIX 1 AA1 SER A 303 PHE A 307 5 5 HELIX 2 AA2 LEU A 308 LEU A 317 1 10 HELIX 3 AA3 CYS A 345 GLY A 352 1 8 HELIX 4 AA4 GLU A 353 LEU A 358 5 6 HELIX 5 AA5 ARG A 359 MET A 380 1 22 HELIX 6 AA6 ALA A 430 GLY A 437 1 8 HELIX 7 AA7 ILE A 441 THR A 456 1 16 HELIX 8 AA8 ARG A 469 ARG A 477 1 9 HELIX 9 AA9 PRO A 488 TRP A 499 1 12 HELIX 10 AB1 THR A 508 ASP A 518 1 11 HELIX 11 AB2 ASP A 518 THR A 523 1 6 HELIX 12 AB3 PRO B 263 GLU B 265 5 3 HELIX 13 AB4 ALA B 311 LYS B 316 1 6 HELIX 14 AB5 CYS B 345 LYS B 351 1 7 HELIX 15 AB6 GLU B 353 LEU B 358 5 6 HELIX 16 AB7 ARG B 359 MET B 380 1 22 HELIX 17 AB8 GLU B 432 GLY B 437 1 6 HELIX 18 AB9 THR B 440 THR B 457 1 18 HELIX 19 AC1 VAL B 467 GLU B 476 1 10 HELIX 20 AC2 PRO B 488 TRP B 499 1 12 HELIX 21 AC3 THR B 508 ASP B 518 1 11 HELIX 22 AC4 ASP B 518 THR B 523 1 6 SHEET 1 AA1 2 LEU A 267 ARG A 268 0 SHEET 2 AA1 2 THR A 285 TRP A 286 -1 O THR A 285 N ARG A 268 SHEET 1 AA2 4 GLU A 280 TRP A 282 0 SHEET 2 AA2 4 VAL A 292 THR A 296 -1 O THR A 296 N GLU A 280 SHEET 3 AA2 4 TYR A 335 GLU A 339 -1 O MET A 338 N ALA A 293 SHEET 4 AA2 4 LEU A 325 VAL A 329 -1 N ALA A 327 O VAL A 337 SHEET 1 AA3 2 TYR A 382 VAL A 383 0 SHEET 2 AA3 2 ARG A 409 LEU A 410 -1 O ARG A 409 N VAL A 383 SHEET 1 AA4 2 ILE A 392 VAL A 394 0 SHEET 2 AA4 2 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 AA5 5 LEU B 267 GLY B 274 0 SHEET 2 AA5 5 GLU B 280 TRP B 286 -1 O VAL B 281 N LEU B 273 SHEET 3 AA5 5 THR B 290 THR B 296 -1 O ILE B 294 N TRP B 282 SHEET 4 AA5 5 TYR B 335 MET B 338 -1 O ILE B 336 N LYS B 295 SHEET 5 AA5 5 VAL B 328 VAL B 329 -1 N VAL B 329 O TYR B 335 SHEET 1 AA6 2 ILE B 392 VAL B 394 0 SHEET 2 AA6 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 CISPEP 1 GLU A 332 PRO A 333 0 -1.58 CISPEP 2 LEU B 308 GLN B 309 0 0.66 CISPEP 3 GLU B 332 PRO B 333 0 -2.93 CISPEP 4 PHE B 424 PRO B 425 0 3.96 SITE 1 AC1 9 LEU A 273 GLY A 274 MET A 338 GLU A 339 SITE 2 AC1 9 TYR A 340 MET A 341 SER A 342 GLY A 344 SITE 3 AC1 9 LEU A 393 SITE 1 AC2 7 LEU B 273 ALA B 293 GLU B 339 TYR B 340 SITE 2 AC2 7 MET B 341 GLY B 344 LEU B 393 SITE 1 AC3 13 ALA A 259 ASN A 287 ILE B 262 PRO B 263 SITE 2 AC3 13 GLU B 265 SER B 266 LEU B 267 LEU B 297 SITE 3 AC3 13 VAL B 329 GLU B 331 GLU B 332 ILE B 334 SITE 4 AC3 13 TYR B 335 SITE 1 AC4 7 TRP B 260 TRP B 286 LEU B 325 TYR B 326 SITE 2 AC4 7 VAL B 328 ILE B 336 MET B 338 SITE 1 AC5 8 GLY B 344 LEU B 346 LEU B 347 PHE B 349 SITE 2 AC5 8 LEU B 350 GLY B 352 ALA B 390 ILE B 392 SITE 1 AC6 8 GLY B 344 LEU B 346 LEU B 347 PHE B 349 SITE 2 AC6 8 LEU B 350 GLY B 352 ALA B 390 ILE B 392 CRYST1 42.270 63.790 74.970 101.56 89.91 89.98 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023657 -0.000008 -0.000038 0.00000 SCALE2 0.000000 0.015676 0.003205 0.00000 SCALE3 0.000000 0.000000 0.013615 0.00000